LATEST ALERTS

District of Columbia - United States Medical cannabis bill increasing access becomes law…
United States - Washington Interstate cannabis trade bill passes Senate and heads to House…
South Dakota - United States Governor vetoes industrial hemp revision bill…
South Dakota - United States Medical cannabis use prohibited if pregnant or breastfeeding…
South Dakota - United States Governor signs bill on medical cannabis qualifying conditions…
Oklahoma - United States Medical cannabis-related bill passes Senate…
Kentucky - United States Delta-8 THC bill signed by governor and becomes law…
Europe EC reveals environmental claims proposal…
Spain Parties rally behind Podemos proposal for hemp regulation…
Maryland - United States Personal use cannabis good, ‘volume dealing’ bad, House says…
North Dakota - United States Legislature approves easier cannabis rules for over-65s in hospices…
New Hampshire - United States House backs home growing for medical cannabis patients…

View all

News analysis

CBD suffering reputational damage from FDA probe and reports of bad labelling

Written by CannIntelligence || 10th November 2020 || News analysis | US federal regulation | Geographies: North America United States

Well reported studies of labelling issues give unfair bad press to CBD – but it is an issue the industry urgently needs to address, according to speakers at the Food and Drug Law Institute’s annual conference ...

Are you already a subscriber? login here

Enjoy free subscription access

Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.

I WANT A FREE TRIAL NOW